Intuitive Surgical (ISRG)
464.45
+0.00 (0.00%)
NASDAQ · Last Trade: Apr 2nd, 9:38 AM EDT
As of April 1, 2026, the global medical technology landscape is undergoing a profound shift, and at the center of this evolution is Medtronic plc (NYSE: MDT). Long regarded as the "sleeping giant" of the healthcare sector, Medtronic has spent the last three years in the throes of a massive structural and cultural overhaul. Today, [...]
Via Finterra · April 1, 2026
As we enter the second quarter of 2026, Johnson & Johnson (NYSE: JNJ) stands as a starkly different entity than the consumer-facing conglomerate that defined the 20th century. Having successfully shed its legacy consumer health business and weathered the initial storm of its largest patent cliff in a decade, J&J has rebranded itself as a [...]
Via Finterra · April 1, 2026
The healthcare leader has seen better times.
Via The Motley Fool · March 27, 2026
Intuitive Surgical Inc (NASDAQ:ISRG) Combines Strong Fundamentals with Technical Breakout Setupchartmill.com
Via Chartmill · March 24, 2026
Intuitive Surgical Inc (NASDAQ:ISRG) Presents a Compelling Mix of Strong Fundamentals and a Bullish Technical Setupchartmill.com
Via Chartmill · February 24, 2026
What Happened? A number of stocks fell in the afternoon session after major indices including the S&P 500 and Dow Jones Industrial Average fell sharply as in...
Via StockStory · March 27, 2026
Companies with more cash than debt can be financially resilient, but that doesn’t mean they’re all strong investments. Some lack leverage because they strugg...
Via StockStory · March 27, 2026
Via MarketBeat · March 26, 2026
These two stocks make fantastic long-term holdings.
Via The Motley Fool · March 22, 2026
Profitability is a key measure of business strength. Companies with high margins have proven they can generate consistent earnings while maintaining financia...
Via StockStory · March 19, 2026
These investments could help you sleep peacefully at night.
Via The Motley Fool · March 17, 2026
Intuitive Surgical business momentum has been spectacular recently. But what should investors make of the valuation?
Via The Motley Fool · March 12, 2026
Intuitive Surgical has had an impressive run over the past six months as its shares have beaten the S&P 500 by 6.4%. The stock now trades at $491.85, marking...
Via StockStory · March 12, 2026
They are down, but they are not out.
Via The Motley Fool · March 10, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Players catalyzing medical advancements have benefited from eleva...
Via StockStory · March 9, 2026
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the surgical equipment & consumables - specialty stocks, including Intuitive Surgical (NASDAQ:ISRG) and its peers.
Via StockStory · March 1, 2026
Intuitive Surgical is the example to keep in mind as you watch this sleeper stock and its new surgical robot.
Via The Motley Fool · March 1, 2026

One of the biggest growth stories in medical devices is Intuitive Surgical, but don't overlook the opportunity ahead for this competitor.
Via The Motley Fool · February 26, 2026

The First Trust RBA American Industrial Renaissance ETF targets small and mid-cap U.S. industrial and community banking companies.
Via The Motley Fool · February 26, 2026
Jensen Huang Says the "ChatGPT Moment" for Physical AI Has Arrived. Here Are 2 Stocks to Buy for 2026.fool.com
Via The Motley Fool · February 25, 2026
Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered safety but lacked the high-octane growth of its specialized med-tech peers. That narrative is shifting rapidly. Today, February 24, 2026, marks a watershed moment for [...]
Via Finterra · February 24, 2026
In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third fiscal quarter of 2026. On February 17, 2026, the Dublin-based medical device giant announced total revenue of $9.017 billion,
Via MarketMinute · February 23, 2026
The company's years of beating the market aren't over yet.
Via The Motley Fool · February 22, 2026
Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive.
Via The Motley Fool · February 20, 2026